Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngoscopy | 15 | 2022 | 710 | 3.010 |
Why?
|
| Larynx | 6 | 2022 | 494 | 2.380 |
Why?
|
| Laryngeal Diseases | 4 | 2021 | 241 | 2.000 |
Why?
|
| Microsurgery | 5 | 2021 | 796 | 1.830 |
Why?
|
| Vocal Cord Paralysis | 7 | 2022 | 267 | 1.590 |
Why?
|
| Voice Quality | 3 | 2017 | 217 | 0.950 |
Why?
|
| Monitoring, Intraoperative | 3 | 2021 | 957 | 0.950 |
Why?
|
| Laryngostenosis | 2 | 2017 | 161 | 0.920 |
Why?
|
| Parkinsonian Disorders | 2 | 2020 | 275 | 0.910 |
Why?
|
| Vocal Cords | 8 | 2022 | 528 | 0.880 |
Why?
|
| Voice Disorders | 3 | 2023 | 276 | 0.810 |
Why?
|
| Voice | 3 | 2023 | 259 | 0.800 |
Why?
|
| Dystonia | 3 | 2020 | 363 | 0.770 |
Why?
|
| Dystonic Disorders | 2 | 2019 | 329 | 0.770 |
Why?
|
| Aerosols | 2 | 2020 | 625 | 0.770 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2020 | 118 | 0.680 |
Why?
|
| Tracheostomy | 2 | 2020 | 401 | 0.670 |
Why?
|
| Hypoglossal Nerve | 2 | 2016 | 95 | 0.650 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.620 |
Why?
|
| Occupations | 2 | 2017 | 517 | 0.620 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2013 | 213 | 0.600 |
Why?
|
| Narcotics | 1 | 2019 | 343 | 0.570 |
Why?
|
| Dysphonia | 3 | 2019 | 144 | 0.550 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2019 | 372 | 0.510 |
Why?
|
| Denervation | 1 | 2016 | 278 | 0.510 |
Why?
|
| Choice Behavior | 2 | 2017 | 802 | 0.500 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 547 | 0.490 |
Why?
|
| Electromyography | 6 | 2022 | 1379 | 0.490 |
Why?
|
| Granuloma, Laryngeal | 1 | 2013 | 8 | 0.480 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 16 | 0.460 |
Why?
|
| Patient Preference | 2 | 2017 | 889 | 0.460 |
Why?
|
| Pharyngeal Diseases | 1 | 2014 | 133 | 0.450 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 606 | 0.450 |
Why?
|
| Tongue | 1 | 2016 | 406 | 0.440 |
Why?
|
| Benchmarking | 1 | 2019 | 1042 | 0.440 |
Why?
|
| Otolaryngology | 2 | 2020 | 645 | 0.430 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2569 | 0.420 |
Why?
|
| Dilatation | 1 | 2013 | 291 | 0.410 |
Why?
|
| Pharynx | 1 | 2014 | 413 | 0.410 |
Why?
|
| Neurofibromatoses | 1 | 2016 | 299 | 0.410 |
Why?
|
| Pressure | 3 | 2021 | 1203 | 0.400 |
Why?
|
| Postoperative Complications | 4 | 2022 | 15295 | 0.390 |
Why?
|
| Occupational Health | 1 | 2017 | 808 | 0.380 |
Why?
|
| Viscosupplements | 1 | 2010 | 23 | 0.360 |
Why?
|
| Functional Laterality | 1 | 2017 | 2290 | 0.360 |
Why?
|
| Occupational Diseases | 1 | 2017 | 1469 | 0.340 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 1643 | 0.330 |
Why?
|
| Psychomotor Performance | 1 | 2017 | 1901 | 0.330 |
Why?
|
| Temporomandibular Joint Dysfunction Syndrome | 1 | 2007 | 23 | 0.300 |
Why?
|
| Equipment Design | 4 | 2021 | 3582 | 0.280 |
Why?
|
| Hoarseness | 2 | 2020 | 65 | 0.280 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 491 | 0.280 |
Why?
|
| Facial Pain | 1 | 2007 | 127 | 0.270 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 134 | 0.260 |
Why?
|
| Thyroidectomy | 2 | 2015 | 879 | 0.260 |
Why?
|
| Laryngoscopes | 2 | 2018 | 148 | 0.250 |
Why?
|
| Video Recording | 2 | 2021 | 949 | 0.220 |
Why?
|
| Endoscopy | 1 | 2013 | 1787 | 0.220 |
Why?
|
| Stress, Mechanical | 2 | 2019 | 1686 | 0.220 |
Why?
|
| Quality of Life | 3 | 2020 | 12803 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4561 | 0.210 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 2133 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.210 |
Why?
|
| Paresis | 1 | 2022 | 179 | 0.200 |
Why?
|
| Prospective Studies | 7 | 2022 | 53291 | 0.190 |
Why?
|
| Models, Animal | 2 | 2017 | 2173 | 0.180 |
Why?
|
| Insufflation | 1 | 2020 | 65 | 0.180 |
Why?
|
| Humans | 39 | 2023 | 744376 | 0.170 |
Why?
|
| Glottis | 1 | 2021 | 217 | 0.170 |
Why?
|
| Injections, Intramuscular | 2 | 2013 | 552 | 0.170 |
Why?
|
| Headache | 1 | 2007 | 1226 | 0.170 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2213 | 0.170 |
Why?
|
| Adult | 20 | 2022 | 214056 | 0.160 |
Why?
|
| Sickness Impact Profile | 1 | 2019 | 302 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2005 | 1002 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2017 | 23336 | 0.150 |
Why?
|
| Middle Aged | 16 | 2021 | 213388 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18034 | 0.150 |
Why?
|
| Female | 25 | 2021 | 380200 | 0.140 |
Why?
|
| Swine | 2 | 2017 | 5918 | 0.140 |
Why?
|
| Male | 20 | 2021 | 350118 | 0.130 |
Why?
|
| Wakefulness | 1 | 2022 | 1245 | 0.130 |
Why?
|
| Laryngeal Mucosa | 1 | 2015 | 31 | 0.130 |
Why?
|
| Injections | 3 | 2021 | 840 | 0.130 |
Why?
|
| Myosins | 1 | 2016 | 409 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 657 | 0.120 |
Why?
|
| Dogs | 2 | 2016 | 3912 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15078 | 0.120 |
Why?
|
| Laryngeal Muscles | 1 | 2013 | 98 | 0.110 |
Why?
|
| Hyoid Bone | 1 | 2012 | 38 | 0.100 |
Why?
|
| Thyroid Cartilage | 1 | 2012 | 42 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77459 | 0.100 |
Why?
|
| Atrophy | 1 | 2016 | 1584 | 0.100 |
Why?
|
| Aged | 9 | 2021 | 163284 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2015 | 691 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19905 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1157 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2013 | 578 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2016 | 985 | 0.090 |
Why?
|
| Software | 2 | 2021 | 4442 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 840 | 0.090 |
Why?
|
| Needles | 1 | 2012 | 449 | 0.080 |
Why?
|
| Aphasia | 1 | 2010 | 184 | 0.080 |
Why?
|
| Gels | 1 | 2010 | 427 | 0.080 |
Why?
|
| Logistic Models | 2 | 2021 | 13409 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3395 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2021 | 9849 | 0.080 |
Why?
|
| Checklist | 1 | 2015 | 833 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 494 | 0.080 |
Why?
|
| Fibrosis | 1 | 2014 | 2029 | 0.080 |
Why?
|
| Masticatory Muscles | 1 | 2007 | 29 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4185 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2017 | 8319 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1438 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2010 | 1899 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1584 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39052 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5390 | 0.060 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 694 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3888 | 0.060 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2004 | 118 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 2291 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.050 |
Why?
|
| Electrodes | 1 | 2005 | 619 | 0.050 |
Why?
|
| Lymphokines | 2 | 2003 | 949 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20130 | 0.050 |
Why?
|
| Animals | 5 | 2017 | 168770 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2282 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Rhinoplasty | 1 | 2005 | 226 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5857 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 15221 | 0.050 |
Why?
|
| Laryngoplasty | 1 | 2021 | 53 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8386 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2020 | 137 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9647 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2020 | 446 | 0.040 |
Why?
|
| Apnea | 1 | 2020 | 195 | 0.040 |
Why?
|
| Growth Substances | 1 | 2001 | 784 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6234 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2001 | 231 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2001 | 535 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 72295 | 0.040 |
Why?
|
| Neuroglia | 1 | 2003 | 928 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 1739 | 0.040 |
Why?
|
| Airway Management | 1 | 2020 | 329 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2013 | 63115 | 0.030 |
Why?
|
| Keratin-13 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1677 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57776 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2020 | 1150 | 0.030 |
Why?
|
| Keratin-14 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Stroboscopy | 1 | 2015 | 64 | 0.030 |
Why?
|
| Laryngeal Nerves | 1 | 2015 | 56 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12961 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 506 | 0.030 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2015 | 139 | 0.030 |
Why?
|
| Adolescent | 3 | 2016 | 85784 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2015 | 644 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 695 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2015 | 438 | 0.030 |
Why?
|
| Retina | 1 | 2003 | 2616 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 1876 | 0.030 |
Why?
|
| Syringes | 1 | 2012 | 56 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 743 | 0.020 |
Why?
|
| Vimentin | 2 | 2003 | 262 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2015 | 1154 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2003 | 772 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 689 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15535 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11366 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2004 | 2736 | 0.020 |
Why?
|
| Rabbits | 1 | 2015 | 4894 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 4982 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 9240 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 29786 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5077 | 0.020 |
Why?
|
| United States | 1 | 2013 | 69869 | 0.020 |
Why?
|
| Neurons | 1 | 2003 | 9340 | 0.010 |
Why?
|
| Esthetics | 1 | 2005 | 306 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2016 | 3444 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2003 | 135 | 0.010 |
Why?
|
| Neck Pain | 1 | 2004 | 180 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12720 | 0.010 |
Why?
|
| Contrast Media | 1 | 2015 | 5300 | 0.010 |
Why?
|
| Arachnoid | 1 | 2001 | 48 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2003 | 3511 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 185 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2001 | 8038 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10484 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 687 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 24252 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 599 | 0.010 |
Why?
|
| Amyloid | 1 | 2001 | 795 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 2700 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25041 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 878 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2001 | 748 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3873 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4458 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 56434 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 81202 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_